EDN1 and chondrosarcoma: Pretreatment of chondrosarcoma cells with the ETAR antagonist BQ123 and the ETBR antagonist BQ788 abolished ET-1-induced wound healing (Figure 3A), migration (Figure 3B), and invasion (Figure 3C).